HeraMED Limited (HMD.AX)
- Previous Close
0.0190 - Open
0.0170 - Bid 0.0160 x --
- Ask 0.0190 x --
- Day's Range
0.0170 - 0.0190 - 52 Week Range
0.0130 - 0.0310 - Volume
191,959 - Avg. Volume
1,369,250 - Market Cap (intraday)
16.636M - Beta (5Y Monthly) 0.34
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It also provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a remote fetal heart rate monitoring solution. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform; and Broward Health for deployment of its HeraCARE to deliver care outcomes for pregnant mothers. HeraMED Limited was founded in 2011 and is based in Camberwell, Australia.
www.hera-med.comRecent News: HMD.AX
View MorePerformance Overview: HMD.AX
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HMD.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HMD.AX
View MoreValuation Measures
Market Cap
16.64M
Enterprise Value
14.32M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
27.73
Price/Book (mrq)
6.00
Enterprise Value/Revenue
39.32
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-91.62%
Return on Equity (ttm)
-317.64%
Revenue (ttm)
364.33k
Net Income Avi to Common (ttm)
-5.49M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
3.17M
Total Debt/Equity (mrq)
2.96%
Levered Free Cash Flow (ttm)
-2.75M